Congress Resolved the Shutdown, Yet Sacrificed THC Product Legalization in a Last-Minute Agreement That May Transform the Cannabis Industry
Government Shutdown Ends: Congress passed a funding bill that ended a record-long government shutdown, but it included a controversial provision that criminalizes several THC-infused and hemp-derived products previously legalized under the 2018 Farm Bill.
Impact on Hemp Industry: The new provision could eliminate nearly all legal hemp products, affecting farmers and overriding existing state laws, as warned by Senator Rand Paul, who emphasized the importance of hemp for farmers facing rising costs.
Market Reactions: The stock market response is mixed; while some multi-state operators may benefit from reduced competition, companies like Tilray Brands Inc. and others with exposure to hemp-derived THC products have seen significant declines.
Future of Cannabis Regulation: The situation raises concerns about the future of cannabis regulation, with calls for a more targeted approach to address issues in the industry rather than broad prohibitions that could harm legitimate businesses.
Trade with 70% Backtested Accuracy
Analyst Views on WEED
No data
About the author
Marijuana Companies Set to Receive Significant Tax Relief as Regulations Relax
- Market Reaction: Traders are currently driving down the prices of pot stocks.
- Executive Order Impact: The negative sentiment may overlook the potential positive effects of President Trump's executive order aimed at reducing restrictions on cannabis products.
Tilray and Canopy Growth Shares Decline Following Trump's Marijuana Rescheduling
- Cannabis Stock Reaction: Cannabis stocks experienced a decline on Thursday.
- Executive Order Impact: The drop followed President Donald Trump's signing of an executive order to reschedule marijuana as a lower-class drug.
Tilray and Cannabis Shares Surge Anticipating Trump's Upcoming Executive Order on Marijuana
- Cannabis Stock Surge: Cannabis stocks experienced a significant increase on Thursday.
- Trump's Executive Order: The rise is attributed to expectations that President Donald Trump will sign an executive order to reschedule marijuana as a lower-class drug.
Marijuana Stocks Surge as Trump Prepares to Sign Executive Order for Drug Reclassification
Cannabis Stock Surge: Cannabis stocks rose on Thursday morning following news that President Trump is expected to sign an executive order to reschedule marijuana.
Rescheduling Marijuana: The proposed change would reclassify marijuana from a Schedule I drug, which includes substances like heroin, to a Schedule III drug, aligning it with some prescription medications.
Market Reaction: The cannabis sector had already seen a surge in stock prices the previous week due to preliminary reports about Trump's intentions regarding marijuana classification.
Implications of Rescheduling: Rescheduling marijuana could have significant implications for its legality, regulation, and market dynamics in the United States.
Cannabis ETF (WEED) Reaches New 52-Week Peak
ETF Performance: The Roundhill Cannabis ETF (WEED) has reached a 52-week high, increasing by 226.5% from its low of $8.79 per share, attracting investor interest.
Market Drivers: Recent gains in cannabis stocks are attributed to President Trump's potential plans to ease federal marijuana regulations, which has boosted optimism among investors.
Future Outlook: The ETF shows a positive weighted alpha of 43.48, indicating the possibility of continued strong performance in the near term.
Investment Resources: Zacks Investment Research offers a free newsletter with actionable insights and top-performing ETFs, encouraging investors to stay informed.
Last Week's Six Best-Performing ETF Sectors
Market Performance: Last week, the S&P 500 fell by 0.6%, while the Dow Jones rose by 1.1% and the Nasdaq dropped by 1.6%, primarily due to declines in tech stocks, including a 14% drop in Oracle's shares.
Federal Reserve Actions: The Fed implemented its final rate cut of the year, lowering the benchmark federal funds rate to 3.5%-3.75%, with projections indicating a more restrained outlook for 2026.
ETF Highlights: Notable ETF performances included significant gains in the cannabis sector, with the Roundhill Cannabis ETF up 51.2%, and strong performances in silver miners and the space economy, driven by rising demand and investor interest.
Emerging Trends: The Roundhill GLP-1 & Weight Loss ETF gained 6.3%, reflecting optimism in weight loss drugs as a major advancement in pharmaceuticals, while platinum prices surged due to anticipated market deficits.
Marijuana Companies Set to Receive Significant Tax Relief as Regulations Relax
- Market Reaction: Traders are currently driving down the prices of pot stocks.
- Executive Order Impact: The negative sentiment may overlook the potential positive effects of President Trump's executive order aimed at reducing restrictions on cannabis products.
Tilray and Canopy Growth Shares Decline Following Trump's Marijuana Rescheduling
- Cannabis Stock Reaction: Cannabis stocks experienced a decline on Thursday.
- Executive Order Impact: The drop followed President Donald Trump's signing of an executive order to reschedule marijuana as a lower-class drug.
Tilray and Cannabis Shares Surge Anticipating Trump's Upcoming Executive Order on Marijuana
- Cannabis Stock Surge: Cannabis stocks experienced a significant increase on Thursday.
- Trump's Executive Order: The rise is attributed to expectations that President Donald Trump will sign an executive order to reschedule marijuana as a lower-class drug.
Marijuana Stocks Surge as Trump Prepares to Sign Executive Order for Drug Reclassification
Cannabis Stock Surge: Cannabis stocks rose on Thursday morning following news that President Trump is expected to sign an executive order to reschedule marijuana.
Rescheduling Marijuana: The proposed change would reclassify marijuana from a Schedule I drug, which includes substances like heroin, to a Schedule III drug, aligning it with some prescription medications.
Market Reaction: The cannabis sector had already seen a surge in stock prices the previous week due to preliminary reports about Trump's intentions regarding marijuana classification.
Implications of Rescheduling: Rescheduling marijuana could have significant implications for its legality, regulation, and market dynamics in the United States.
Cannabis ETF (WEED) Reaches New 52-Week Peak
ETF Performance: The Roundhill Cannabis ETF (WEED) has reached a 52-week high, increasing by 226.5% from its low of $8.79 per share, attracting investor interest.
Market Drivers: Recent gains in cannabis stocks are attributed to President Trump's potential plans to ease federal marijuana regulations, which has boosted optimism among investors.
Future Outlook: The ETF shows a positive weighted alpha of 43.48, indicating the possibility of continued strong performance in the near term.
Investment Resources: Zacks Investment Research offers a free newsletter with actionable insights and top-performing ETFs, encouraging investors to stay informed.
Last Week's Six Best-Performing ETF Sectors
Market Performance: Last week, the S&P 500 fell by 0.6%, while the Dow Jones rose by 1.1% and the Nasdaq dropped by 1.6%, primarily due to declines in tech stocks, including a 14% drop in Oracle's shares.
Federal Reserve Actions: The Fed implemented its final rate cut of the year, lowering the benchmark federal funds rate to 3.5%-3.75%, with projections indicating a more restrained outlook for 2026.
ETF Highlights: Notable ETF performances included significant gains in the cannabis sector, with the Roundhill Cannabis ETF up 51.2%, and strong performances in silver miners and the space economy, driven by rising demand and investor interest.
Emerging Trends: The Roundhill GLP-1 & Weight Loss ETF gained 6.3%, reflecting optimism in weight loss drugs as a major advancement in pharmaceuticals, while platinum prices surged due to anticipated market deficits.
